Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine/Cisplatin vs Gemcitabine/Epirubicin in Stage IIIB/IV NSCLC
NCT00154739Phase 2Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Oct 1998
- Primary completion
- Jul 2005
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, randomised trial of epirubicin in non-small cell lung cancer (NSCLC) (2 arms), sponsored by National Taiwan University Hospital. Started Oct 1998; status: completed.
02
Drugs
epirubicin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00154739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00154739.